(R) -STU104

(R) -STU104 is a novel small molecule PPI inhibitor that targets the TAK1-MKK3 interaction, thereby suppressing the downstream p38 MAPK signaling pathway and TNF-α production. It has demonstrated efficacy in preclinical in vivo models, making it a candidate for research in inflammatory diseases such as ulcerative colitis.